TLR9 and psoriasis: We considered the antimicrobial peptide LL-37 as a potential candidate based on a recent report that LL-37 isolated from psoriasis skin lesions can bind DNA and trigger peripheral blood pDC to secrete IFN-α via TLR-9 [29].